Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action

Karl Erik Andersson, William C. De Groat, Kevin T. McVary, Tom F. Lue, Mario Maggi, Claus Roehrborn, Jean Jacques Wyndaele, Thomas Melby, Lars Viktrup

Research output: Contribution to journalReview articlepeer-review

190 Scopus citations

Fingerprint

Dive into the research topics of 'Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action'. Together they form a unique fingerprint.

Medicine & Life Sciences